Introduction
Immunosuppression caused by agents used in the treatment of leukaemia may be important for two reasons. Firstly, the more the patient's immunological function is impaired the more susceptible to infection he is likely to be. The increased risk of fatal infections in patients treated with x-irradiation and cytotoxic drugs is well recognized. Secondly, true cure of leukaemia may be dependent on an effective immune response in the patient against his own neoplastic cells, or possibly against a causative agent. Attempts are continuing to treat leukaemia with active immunotherapy (Mathe, 1971; Crowther et al., 1973) . If such treatment is to be adequately tested it will be important to know the relative immunosuppressive effects of different therapeutic regimens.
The recognition of functionally distinct subpopulations of human lymphocytes, and the development of test systems by which they may be quantitated, offers the possibility of more *For composition of Working Party see accompanying paper, p. (Harding et al., 1971; Campbell et al., 1972) . These cells, however, are probably a separate subpopulation from those B lymphocytes which are the precursors of antibody-producing cells (Harding and MacLennan, 1972) . We describe them as cytotoxic "B" cells only because we are confident that they are not thymusdependent lymphocytes.
We have applied these three assays to the lymphocytes of patients with acute lymphoblastic leukaemia who have been treated in the trial of "prophylactic" radiotherapy which is reported in an accompanying paper (Medical Research Council, 1973) . We describe the results obtained on patients who were still in first remission after 18 months' treatment. Follow-up studies on these patients are in progress to assess the changes occurring in lymphocyte subpopulations after this time, when the patients are being randomized to three groups: (1) to have no further treatment, (2) to continue with chemotherapy, and (3) to receive a short course of active immunotherapy. The results of these studies will be published at a later date.
Patients and Methods
All the children studied were patients in the trial of "prophylactic" central nervous system (C.N.S.) irradiation described in the accompanying paper (Medical Research Council, 1973) . After the initial induction phase of treatment, patients in complete remission were divided into a group that received craniospinal irradiation and a group that received no C.N.S. "prophylaxis." Subsequently, all these patients were given identical cycles of chemotherapy, except that the irradiated patients were given intrathecal methotrexate during the first four 12-week cycles. Lymphocyte populations were assessed in those patients who were still in first remission at the end of the fifth 12-week cycle of chemotherapy (about 72 weeks after admission). All (Campbell et al., 1973) . Absolute peripheral blood lymphocyte counts were obtained from the routine blood counts performed at the treatment centres. Samples of defibrinated venous blood were sent to Oxford by post for testing of lymphocytes. Most of the samples reached Oxford within 24 hours of collection; those that did not were discarded. In a large series of tests it has been found that storage of defibrinated blood for up to 24 hours at room temperature has only minor effects on the assays of lymphocyte function described here. All samples were tested between 18 and 24 hours after collection. Lymphocytes were harvested from the defibrinated blood by sedimentation at 37°C in gelatine (30' in normal saline) (Coulson and Chalmers, 1964 The results of all assays are plotted on a logarithmic scale for two reasons. Firstly, it has been found in a large series of experiments that the accumulated results of each of these tests in healthy subjects approximate to a normal distribution on a logarithmic scale. Secondly, by using the same scale in plotting the results of the different tests quantitative comparisons are easily made between them. The three assays of lymphocyte subpopulations give results which are related to the proportion of differentlymphocytes in any sample. In measuring immunosuppression it may be more important to obtain results related to the number of such lymphocytes per ml of blood. We have therefore taken into account the peripheral blood lymphocyte counts of the patients at the time the blood was taken for testing. Thus, from the PHA response the mitogenic capacity was calculated as log,0 [(the lymphocyte count per ml of blood) x (the PHA response in counts per minute)]. The mitogenic capacity therefore represents the PHA responsiveness present in 1 ml of patient's blood. From the assay of cytotoxic activity, the cytotoxic capacity is calculated as [log,0 (lymphocyte count per ml) -SC5O]. With the assay of staining for surface immunoglobulin, it is possible to calculate directly the absolute number of staining cells per ml of patient's blood.
We have not so far tested the lymphocytes of a population of healthy children in the same age group as these patients (3 to 17 years). However, "control" ranges are indicated in the figures by central vertical bars. In figs. 2 and 3 these represent the extremes for lymphocyte and neutrophil counts between the ages of 3 and 17 (Geigy, 1970) . In the remaining figures they represent the mean ± 1 S.D. which we have obtained using the lymphocytes of healthy adults in a large series of experiments. We are aware that there may be major differences in lymphocyte function and subpopulations between children and adults. These "control" values are indicated only as reference points. 
Results
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. all of the tests were carried out on both these occasions. It was found that there were no significant differences between the pooled results for each assay system at these two times. The data have, therefore, been combined so that when results were available for a patient on both occasions the mean of the two was taken for analysis. In each figure the combined data are compared for the two groups of patients, irradiated (XRT) and non-irradiated (No XRT).
Lymphocyte Counts.-The lymphocyte counts from children in both groups were below normal ( fig. 2) of blood in the two groups of patients. Staining for surface immunoglobulin was carried out on fewer samples ( fig. 5 ). (Seigel, 1956) . N.S. = Not significant. pronounced suppression of this lymphocyte activity by the chemotherapy. The results of all these assays are summarized in the table.
Discussion
We have observed a number of changes in the blood lymphocytes resulting either from chemotherapy or craniospinal irradiation.
The particular sensitivity of lymphocytes to irradiation and the prolonged lymphopenia which is seen in patients after radiotherapy has often been described (Buckton et al., 1967; Stjernsward et al., 1972) . In this study it is strikingly apparent more than a year after irradiation. The mean lymphocyte count in the irradiated patients was 600/mm3 compared with 1,400/ mm3 in the patients treated with chemotherapy alone. Among the tests applied to the lymphocytes in vitro this difference is reflected in the level of lymphocytes responding to PHA. The distinct trend for the proportion of lymphocytes staining for surface immunoglobulin to be higher in the irradiated than in the non-irradiated children supports the conclusion that the low PHA responsiveness represents a deficiency of T cells. These findings agree with those of Stjernsward et al. (1972) who found that patients who had received radiotherapy for mammary carcinoma showed a prolonged loss of T cells. In that study at least half of the thymus received a substantial dose of irradiation and it is possible that the deficiency of T cells was a consequence of impaired thymic function. The children we have studied received irradiation to the spine, and therefore to a variable degree to the thymus. One of the factors controlling the dose to the thymus was the energy of the apparatus used which included, in different centres, supervoltage, 250 kV, and cobalt sources. We have not found any correlation between the energy of the irradiation source and the degree of depression of PHA response. This suggests that the loss of T cells may not require irradiation of the thvmus itself.
Since there was some variation in the total dose of methotrexate received by the two groups of patients (Medical Research Council, 1973) we have examined our data on this basis but find that the differences between the two groups are not related to dosage of this drug.
In assessing the effects that may be attributable to chemotherapy, the caution must be made that for the lymphocyte subpopulation tests we have only adult control levels with which to compare the patients. There is a depression of the peripheral blood lymphocyte count, which apparently involves all three subpopulations assayed. The lymphocyte assay showing greatest depression was that of cytotoxic activity against antibody-sensitized target cells. The mean cytotoxic capacity in these patients was almost tenfold below the normal adult level. Early results in the serial studies which we are continuing in these patients indicate that after stopping treatment with antileukaemic drugs there is a rapid rise in this lymphocyte subpopulation. We have also found in a group of patients with inflammatory bowel disease that treatment with azathioprine has a profound depressant effect on these cells (Campbell et al., 1973) . Thus, the low levels of cytotoxic "B" lymphocytes found in these patients may have been caused by mercaptopurine, a purine analogue chemically almost identical to azathioprine. The cytotoxic action of these lymphocytes in tumour rejection has been implicated in several animal models (Lamon et al., 1972; Hersey, 1973) . They may be of similar significance in human neoplastic disease.
The depressive effect of irradiation on PHA-responsive T cells has been noted. A proportion of the PHA-responsive cells also appear to be sensitive to the chemotherapy used. In patients who have stopped drug treatment we have observed a rise in PHA response and mitogenic capacity over the following three to five weeks. This rise is seen in both the irradiated and nonirradiated patients, although the difference between these groups remains. This suggests that there may be two types of PHA-responsive cell, one long-lived and radiosensitive, the other short-lived and sensitive to cytotoxic agents such as mercaptopurine.
A positive correlation between our findings and the clinical results may lie in the observation that four patients in the irradiated group have died while in full remission, probably all as the result of infection. None of the non-irradiated patients have died in remission. It is possible that these deaths were the consequence of the immunosuppression, and more particularly the deficiency of long-lived T lymphocytes, which resulted from x-irradiation. However, other possibilities remain. It may be that at an earlier stage the effect of irradiation on neutropbil production and function is of greater importance. Careful correlation with clinical and haematological findings will be necessary before the significance of changes in lymphocyte subpopulations can be assessed.
